Adaptimmune Therapeutics (473A) Ownership - Who Owns Adaptimmune Therapeutics?
Adaptimmune Therapeutics (473A) Ownership Overview
- 0.05% Mutual Funds
- 0.18% Other Institutional Investors
- 99.77% Public Companies and Individual Investors
The ownership structure of Adaptimmune Therapeutics (DE:473A) stock is a mix of institutional, retail, and individual investors. Approximately 0.23% of the company’s stock is owned by Institutional Investors, and 99.77% is owned by Public Companies and Individual Investors.
The ownership structure of Adaptimmune Therapeutics (DE:473A) stock is a mix of institutional, retail, and individual investors. Approximately 0.23% of the company’s stock is owned by Institutional Investors, and 99.77% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Commonwealth Trust Ii | 99,822 | Institution | 0.04% | 1,298 |
| Locorr Investment Trust | 16,257 | Institution | <0.01% | 211 |
| Baillie Gifford Funds | 6,385 | Institution | <0.01% | 83 |
| Harbor Funds | 554 | Institution | <0.01% | 7 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Commonwealth Trust Ii | 99,822 | Institution | 0.04% | 1,298 |
| Locorr Investment Trust | 16,257 | Institution | <0.01% | 211 |
| Baillie Gifford Funds | 6,385 | Institution | <0.01% | 83 |
| Harbor Funds | 554 | Institution | <0.01% | 7 |
FAQ
What percentage of Adaptimmune Therapeutics (DE:473A) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.23% of Adaptimmune Therapeutics (DE:473A) stock is held by institutional investors: 0.05% by mutual funds and 0.18% by other institutional investors.
What percentage of Adaptimmune Therapeutics (DE:473A) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.77% of Adaptimmune Therapeutics (DE:473A) stock is held by public companies and individual investors.
Who owns the most shares of Adaptimmune Therapeutics (DE:473A)?
Fidelity Commonwealth Trust II owns the most shares of Adaptimmune Therapeutics (DE:473A).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.